Literature DB >> 17346197

FtsZ: a novel target for tuberculosis drug discovery.

Qing Huang1, Peter J Tonge, Richard A Slayden, Teruo Kirikae, Iwao Ojima.   

Abstract

The emergence of multi-drug resistant Mycobacterium tuberculosis (Mtb) strains has made many of the currently available anti-TB drugs ineffective. Accordingly there is a pressing need to identify new drug targets. FtsZ, a bacterial tubulin homologue, is an essential cell division protein that polymerizes in a GTP-dependent manner, forming a highly dynamic cytokinetic ring, designated as the Z ring, at the septum site. Following recruitment of other cell division proteins, the Z ring contracts, resulting in closure of the septum and then formation of two daughter cells. Since inactivation of FtsZ or alteration of FtsZ assembly results in the inhibition of Z ring and septum formation, FtsZ is a very promising target for new antimicrobial drug development. This review describes the function and dynamic behaviors of FtsZ, its homology to tubulin, and recent development of FtsZ inhibitors as potential anti-TB agents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17346197     DOI: 10.2174/156802607780059790

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  22 in total

Review 1.  On and around microtubules: an overview.

Authors:  Richard H Wade
Journal:  Mol Biotechnol       Date:  2009-06-30       Impact factor: 2.695

2.  Enterococcal and streptococcal resistance to PC190723 and related compounds: molecular insights from a FtsZ mutational analysis.

Authors:  Malvika Kaul; Yongzheng Zhang; Ajit K Parhi; Edmond J Lavoie; Steve Tuske; Eddy Arnold; John E Kerrigan; Daniel S Pilch
Journal:  Biochimie       Date:  2013-06-25       Impact factor: 4.079

3.  A bactericidal guanidinomethyl biaryl that alters the dynamics of bacterial FtsZ polymerization.

Authors:  Malvika Kaul; Ajit K Parhi; Yongzheng Zhang; Edmond J LaVoie; Steve Tuske; Eddy Arnold; John E Kerrigan; Daniel S Pilch
Journal:  J Med Chem       Date:  2012-10-26       Impact factor: 7.446

4.  Novel trisubstituted benzimidazoles, targeting Mtb FtsZ, as a new class of antitubercular agents.

Authors:  Kunal Kumar; Divya Awasthi; Seung-Yub Lee; Ilaria Zanardi; Bela Ruzsicska; Susan Knudson; Peter J Tonge; Richard A Slayden; Iwao Ojima
Journal:  J Med Chem       Date:  2010-12-02       Impact factor: 7.446

5.  Strategic incorporation of fluorine in the drug discovery of new-generation antitubercular agents targeting bacterial cell division protein FtsZ.

Authors:  Iwao Ojima; Divya Awasthi; Longfei Wei; Krupanandan Haranahalli
Journal:  J Fluor Chem       Date:  2016-07-29       Impact factor: 2.050

6.  An FtsZ-targeting prodrug with oral antistaphylococcal efficacy in vivo.

Authors:  Malvika Kaul; Lilly Mark; Yongzheng Zhang; Ajit K Parhi; Edmond J Lavoie; Daniel S Pilch
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

7.  Substituted 1,6-diphenylnaphthalenes as FtsZ-targeting antibacterial agents.

Authors:  Yongzheng Zhang; Daniel Giurleo; Ajit Parhi; Malvika Kaul; Daniel S Pilch; Edmond J LaVoie
Journal:  Bioorg Med Chem Lett       Date:  2013-02-13       Impact factor: 2.823

Review 8.  Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.

Authors:  Krupanandan Haranahalli; Simon Tong; Iwao Ojima
Journal:  Bioorg Med Chem       Date:  2016-05-05       Impact factor: 3.641

9.  In vitro-in vivo activity relationship of substituted benzimidazole cell division inhibitors with activity against Mycobacterium tuberculosis.

Authors:  Susan E Knudson; Kunal Kumar; Divya Awasthi; Iwao Ojima; Richard A Slayden
Journal:  Tuberculosis (Edinb)       Date:  2014-04-01       Impact factor: 3.131

10.  Design, synthesis and evaluation of novel 2,5,6-trisubstituted benzimidazoles targeting FtsZ as antitubercular agents.

Authors:  Bora Park; Divya Awasthi; Soumya R Chowdhury; Eduard H Melief; Kunal Kumar; Susan E Knudson; Richard A Slayden; Iwao Ojima
Journal:  Bioorg Med Chem       Date:  2014-04-01       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.